Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evidence-Based Evaluation of Naoxintong Capsule in the Treatment of Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial

NCT07698223 is registered in ClinicalTrials.gov with Chen Xiangmei as lead sponsor.

NCT NCT07698223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07698223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evidence-Based Evaluation of Naoxintong Capsule in the Treatment of Diabetic Nephropathy With Dampness Retention Pattern: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Lead sponsor
Chen Xiangmei
Phase
Phase 4
Overall status
Not yet recruiting
Start date
March 1, 2027
Completion date
December 30, 2028
Enrollment
410 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic nephropathy